Pietro Calissano Selected Research

Pietro Calissano Research Topics

Disease

29	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2003
7	Cognitive Dysfunction 01/2021 - 01/2014
6	Amyloid Plaque 10/2016 - 11/2007
6	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 03/2008
5	Tauopathies 12/2019 - 02/2006
4	Necrosis 06/2005 - 03/2002
2	Neuroinflammatory Diseases 11/2021 - 01/2021
2	Insulin Resistance 11/2021 - 01/2019
2	Inflammation (Inflammations) 01/2021 - 01/2014
2	Dementia (Dementias) 01/2014 - 08/2011
1	Type 2 Diabetes Mellitus (MODY) 11/2021
1	Learning Disabilities (Learning Disability) 11/2021
1	Pain (Aches) 01/2021
1	Blindness (Hysterical Blindness) 01/2021
1	Weight Loss (Weight Reduction) 01/2021
1	Macular Degeneration (Age-Related Maculopathy) 01/2021
1	Retinal Diseases 01/2021
1	Retinal Degeneration 01/2021
1	Gliosis 01/2020
1	Starvation 01/2018
1	Prodromal Symptoms 01/2018
1	Neuritis (Polyneuritis) 08/2015
1	Parkinson Disease (Parkinson's Disease) 01/2014
1	Nervous System Diseases (Neurological Disorders) 01/2014
1	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2014
1	Mixed Dementias 01/2014
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2012
1	Synucleinopathies 03/2008
1	Amnesia (Dissociative Amnesia) 12/2003

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2003
13	Amyloid (Amyloid Fibrils)IBA 11/2021 - 01/2003
11	Nerve Growth Factor (NGF)IBA 01/2021 - 12/2012
8	Peptides (Polypeptides)IBA 01/2021 - 02/2008
8	tau Proteins (tau Protein)IBA 01/2021 - 01/2003
6	Amyloid beta-PeptidesIBA 01/2010 - 12/2003
5	Nerve Growth Factors (Neurotrophins)IBA 01/2021 - 01/2003
4	Cholinergic Agents (Cholinergics)IBA 01/2021 - 10/2016
3	Cytochromes c (Cytochrome c)IBA 08/2003 - 03/2002
2	Phosphotransferases (Kinase)IBA 06/2017 - 01/2017
2	TropomyosinIBA 06/2017 - 01/2017
2	Substance PIBA 01/2016 - 01/2013
2	Adenosine Triphosphate (ATP)IBA 04/2012 - 06/2005
2	DNA (Deoxyribonucleic Acid)IBA 09/2006 - 06/2005
2	Glutamic Acid (Glutamate)FDA Link 06/2005 - 03/2002
1	AMP-Activated Protein KinasesIBA 11/2021
1	Streptozocin (Streptozotocin)FDA Link 11/2021
1	Flavin-Adenine Dinucleotide (FAD)IBA 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	Microtubule ProteinsIBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2020
1	AntigensIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2019
1	Insulin ReceptorIBA 01/2019
1	Ubiquitin Thiolesterase (Ubiquitin Carboxy-Terminal Hydrolase)IBA 01/2018
1	UbiquitinIBA 01/2018
1	trkA ReceptorIBA 06/2017
1	MicroRNAs (MicroRNA)IBA 06/2014
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	bindaritIBA 01/2014
1	NeuropeptidesIBA 01/2013
1	Adenosine Diphosphate (ADP)IBA 04/2012
1	Pharmaceutical PreparationsIBA 01/2010
1	EnzymesIBA 01/2010
1	alpha-SynucleinIBA 03/2008
1	Detergents (Detergent)IBA 02/2008
1	PotassiumIBA 09/2006
1	Free RadicalsIBA 09/2006
1	Dizocilpine Maleate (Dizocilpine)IBA 06/2005
1	Citric Acid (Citrate)FDA LinkGeneric 06/2005
1	OligomycinsIBA 06/2005
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2005
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 03/2005
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2003
1	AntioxidantsIBA 03/2003
1	Proteasome InhibitorsIBA 03/2002
1	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2002
1	Fluorescent Dyes (Fluorescent Probes)IBA 03/2002
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 03/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2010
1	Immunotherapy 01/2020
1	Intravenous Administration 01/2020